StreetAccount Summary: EU stocks reaching new 52-week highs/lows (72 total)
argenx completes acquisition of Forte Biosciences ($1047.10, 0.00)
StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Summary - US Pre-market trading update
StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Summary - US Pre-market trading
StreetAccount Summary - European pre-market trading update
argenx upgraded to buy from neutral at UBS ($1019.49, 0.00)
Clarification: argenx downgraded to hold from buy at Deutsche Bank (15:55 CET/09:55 ET) (€874.00, +9.80)
Powered by FactSet Research Systems Inc.